ITCI

Intra-Cellular Therapies Inc.
ITCI

Overview Fund Activity
Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

132 hedge funds and large institutions have $1.53B invested in Intra-Cellular Therapies Inc. in 2015 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 51 increasing their positions, 38 reducing their positions, and 22 closing their positions.

Holders
132
Holders Change
+4
Holders Change %
+3.13%
% of All Funds
3.47%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
26
Increased
51
Reduced
38
Closed
22
Calls
$5.66M
Puts
$16.4M
Net Calls
-$10.7M
Net Calls Change
-$15.4M

Top Buyers

1
Jennison Associates
1
Jennison Associates
New York
$67.7M
2
Millennium Management
2
Millennium Management
New York
$51M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$75.3M
4
FCM
4
Frontier Capital Management
Massachusetts
$16.6M
5
TCM
5
TimesSquare Capital Management
New York
$70.9M

Top Sellers

1
State Street
1
State Street
Massachusetts
$43.4M
2
HCMT
2
Highland Capital Management (Texas)
Texas
$2.78M
3
WA
3
Wasatch Advisors
Utah
$42.6M
4
RCM
4
RA Capital Management
Massachusetts
$0
5
Morgan Stanley
5
Morgan Stanley
New York
$19.2M
Name Market Value Shares Shares
Change 		Shares
Change %
SG Americas Securities
151
SG Americas Securities
New York
– – -2,977 Closed
PG
152
PEAK6 Group
Illinois
– – -2,400 Closed
PAM
153
Panagora Asset Management
Massachusetts
– – -1,684 Closed
QT
154
Quantbot Technologies
New York
– – -616 Closed
ST
155
Spot Trading
Illinois
– – – –
Parallax Volatility Advisers
156
Parallax Volatility Advisers
California
– – – –
SM
157
Sabby Management
Florida
– – – –
3 4 5 6
7